Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      In Switzerland, intravenous drug use accounts for the majority of hepatitis C virus (HCV) infections. Early HCV treatment prevents further transmissions and reduces morbidity and mortality due to decompensated liver cirrhosis and hepatocellular carcinoma. Nevertheless, patients in drug substitution programmes are often insufficiently screened and treated.

      Related collections

      Author and article information

      Affiliations
      [1 ] Department of Infectious Diseases and Hospital Hygiene, Cantonal Hospital Aarau, Switzerland.
      [2 ] Department of Gastroenterology and Hepatology, Cantonal Hospital Aarau, Switzerland.
      [3 ] Department of Infectious Diseases, Cantonal Hospital Baden, Switzerland.
      [4 ] Department of Gastroenterology, Cantonal Hospital Baden, Switzerland.
      [5 ] Psychiatric Clinic Königsfelden, Switzerland.
      [6 ] General Practitioner, Baden, Switzerland.
      [7 ] Cantonal Physician, Canton Aargau, Switzerland.
      Journal
      Swiss Med Wkly
      Swiss medical weekly
      EMH Swiss Medical Publishers, Ltd.
      1424-3997
      0036-7672
      2017
      : 147
      29185250
      10.4414/smw.2017.14544
      smw-14544

      Comments

      Comment on this article